These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 22000706

  • 21. Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease.
    Musaeus CS, Shafi MM, Santarnecchi E, Herman ST, Press DZ.
    J Alzheimers Dis; 2017; 58(4):1065-1076. PubMed ID: 28527204
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Milligan TA, Hurwitz S, Bromfield EB.
    Neurology; 2008 Aug 26; 71(9):665-9. PubMed ID: 18725591
    [Abstract] [Full Text] [Related]

  • 23. Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
    Koo DL, Joo EY, Kim D, Hong SB.
    Epilepsy Res; 2013 Mar 26; 104(1-2):134-9. PubMed ID: 23032070
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Nitrous oxide paradoxically modulates slow electroencephalogram oscillations: implications for anesthesia monitoring.
    Foster BL, Liley DT.
    Anesth Analg; 2011 Oct 26; 113(4):758-65. PubMed ID: 21788312
    [Abstract] [Full Text] [Related]

  • 26. Region and frequency specific changes of spectral power in Alzheimer's disease and mild cognitive impairment.
    Roh JH, Park MH, Ko D, Park KW, Lee DH, Han C, Jo SA, Yang KS, Jung KY.
    Clin Neurophysiol; 2011 Nov 26; 122(11):2169-76. PubMed ID: 21715226
    [Abstract] [Full Text] [Related]

  • 27. Effect of levetiracetam on behavioral problems in pervasive developmental disorder children with epilepsy.
    Kanemura H, Sano F, Ohyama T, Sugita K, Aihara M.
    Eur J Paediatr Neurol; 2014 Jul 26; 18(4):482-8. PubMed ID: 24703761
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of levetiracetam on generalized discharges monitored with ambulatory EEG in epileptic patients.
    Pro S, Vicenzini E, Pulitano P, Li Voti P, Zarabla A, Randi F, Mecarelli O.
    Seizure; 2009 Mar 26; 18(2):133-8. PubMed ID: 18835193
    [Abstract] [Full Text] [Related]

  • 31. Levetiracetam as a treatment option in non-convulsive status epilepticus.
    Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G.
    Epilepsy Res; 2007 Mar 26; 73(3):238-44. PubMed ID: 17161587
    [Abstract] [Full Text] [Related]

  • 32. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
    Varoglu AO, Yildirim A, Aygul R, Gundogdu OL, Sahin YN.
    Clin Neuropharmacol; 2010 May 26; 33(3):155-7. PubMed ID: 20502135
    [Abstract] [Full Text] [Related]

  • 33. Saliva and serum levetiracetam concentrations in patients with epilepsy.
    Mecarelli O, Li Voti P, Pro S, Romolo FS, Rotolo M, Pulitano P, Accornero N, Vanacore N.
    Ther Drug Monit; 2007 Jun 26; 29(3):313-8. PubMed ID: 17529888
    [Abstract] [Full Text] [Related]

  • 34. Levetiracetam for people with mental retardation and refractory epilepsy.
    Kelly K, Stephen LJ, Brodie MJ.
    Epilepsy Behav; 2004 Dec 26; 5(6):878-83. PubMed ID: 15582836
    [Abstract] [Full Text] [Related]

  • 35. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
    Mecarelli O, Vicenzini E, Pulitano P, Vanacore N, Romolo FS, Di Piero V, Lenzi GL, Accornero N.
    Ann Pharmacother; 2004 Nov 26; 38(11):1816-22. PubMed ID: 15367726
    [Abstract] [Full Text] [Related]

  • 36. Does greater low frequency EEG activity in normal immaturity and in children with epilepsy arise in the same neuronal network?
    Michels L, Bucher K, Brem S, Halder P, Lüchinger R, Liechti M, Martin E, Jeanmonod D, Kröll J, Brandeis D.
    Brain Topogr; 2011 Mar 26; 24(1):78-89. PubMed ID: 20820898
    [Abstract] [Full Text] [Related]

  • 37. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ, Arif H, Buchsbaum R, Weintraub D, Lee J, Chang JT, Resor SR, Bazil CW.
    Epilepsia; 2007 Jul 26; 48(7):1351-9. PubMed ID: 17573925
    [Abstract] [Full Text] [Related]

  • 38. Encephalopathy induced by levetiracetam added to valproate.
    Bauer J.
    Acta Neurol Scand; 2008 May 26; 117(5):374-6. PubMed ID: 18081909
    [Abstract] [Full Text] [Related]

  • 39. Cognition across the lifespan: antiepileptic drugs, epilepsy, or both?
    Hermann B, Meador KJ, Gaillard WD, Cramer JA.
    Epilepsy Behav; 2010 Jan 26; 17(1):1-5. PubMed ID: 19931492
    [Abstract] [Full Text] [Related]

  • 40. Levetiracetam monotherapy in juvenile myoclonic epilepsy.
    Sharpe DV, Patel AD, Abou-Khalil B, Fenichel GM.
    Seizure; 2008 Jan 26; 17(1):64-8. PubMed ID: 17692537
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.